Literature DB >> 20654589

Sprouting of corticospinal tract axons from the contralateral hemisphere into the denervated side of the spinal cord is associated with functional recovery in adult rat after traumatic brain injury and erythropoietin treatment.

Yanlu Zhang1, Ye Xiong, Asim Mahmood, Yuling Meng, Zhongwu Liu, Changsheng Qu, Michael Chopp.   

Abstract

Erythropoietin (EPO) promotes functional recovery after traumatic brain injury (TBI). This study was designed to investigate whether EPO treatment promotes contralateral corticospinal tract (CST) plasticity in the spinal cord in rats after TBI. Biotinylated dextran amine (BDA) was injected into the right sensorimotor cortex to anterogradely label the CST. TBI was induced by controlled cortical impact over the left parietal cortex immediately after BDA injections. EPO (5000 U/kg) or saline was administered intraperitoneally at Days 1, 2, and 3 post-injury. Neurological function was assessed using a modified neurological severity score (mNSS) and footfault tests. Animals were sacrificed 35 days after injury and brain sections stained for histological analysis. Compared to the saline treatment, EPO treatment significantly improved sensorimotor functional outcome (lower mNSS and reduced footfaults) from Days 7 to 35 post-injury. TBI alone significantly stimulated contralateral CST axon sprouting toward the denervated gray matter of the cervical and lumbar spinal cord; however, EPO treatment further significantly increased the axon sprouting in TBI rats although EPO treatment did not significantly affect axon sprouting in sham animals. The contralesional CST sprouting was highly and positively correlated with sensorimotor recovery after TBI. These data demonstrate that CST fibers originating from the contralesional intact cerebral hemisphere are capable of sprouting into the denervated spinal cord after TBI and EPO treatment, which may at least partially contribute to functional recovery. Copyright 2010 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  axonal plasticity; erythropoietin; functional recovery; rats; traumatic brain injury

Mesh:

Substances:

Year:  2010        PMID: 20654589      PMCID: PMC2933297          DOI: 10.1016/j.brainres.2010.07.046

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  44 in total

1.  Erythropoietin enhances neurogenesis and restores spatial memory in rats after traumatic brain injury.

Authors:  Dunyue Lu; Asim Mahmood; Changsheng Qu; Anton Goussev; Timothy Schallert; Michael Chopp
Journal:  J Neurotrauma       Date:  2005-09       Impact factor: 5.269

2.  Axonal plasticity is associated with motor recovery following amphetamine treatment combined with rehabilitation after brain injury in the adult rat.

Authors:  Maya Ramic; April J Emerick; Melanie R Bollnow; Timothy E O'Brien; Shih-Yen Tsai; Gwendolyn L Kartje
Journal:  Brain Res       Date:  2006-08-21       Impact factor: 3.252

3.  Delayed inhibition of Nogo-A does not alter injury-induced axonal sprouting but enhances recovery of cognitive function following experimental traumatic brain injury in rats.

Authors:  P M Lenzlinger; S Shimizu; N Marklund; H J Thompson; M E Schwab; K E Saatman; R C Hoover; F M Bareyre; M Motta; A Luginbuhl; R Pape; A K Clouse; C Morganti-Kossmann; T K McIntosh
Journal:  Neuroscience       Date:  2005       Impact factor: 3.590

4.  Neuroprotection with erythropoietin administration following controlled cortical impact injury in rats.

Authors:  Leela Cherian; J Clay Goodman; Claudia Robertson
Journal:  J Pharmacol Exp Ther       Date:  2007-04-30       Impact factor: 4.030

5.  Collagen scaffolds populated with human marrow stromal cells reduce lesion volume and improve functional outcome after traumatic brain injury.

Authors:  Dunyue Lu; Asim Mahmood; Changsheng Qu; Xin Hong; David Kaplan; Michael Chopp
Journal:  Neurosurgery       Date:  2007-09       Impact factor: 4.654

6.  Axonal sprouting into the denervated spinal cord and synaptic and postsynaptic protein expression in the spinal cord after transplantation of bone marrow stromal cell in stroke rats.

Authors:  Zhongwu Liu; Yi Li; Runjiang Qu; Lihong Shen; Qi Gao; Xueguo Zhang; Mei Lu; Smita Savant-Bhonsale; Jade Borneman; Michael Chopp
Journal:  Brain Res       Date:  2007-02-27       Impact factor: 3.252

7.  Treatment of traumatic brain injury in rats with erythropoietin and carbamylated erythropoietin.

Authors:  Asim Mahmood; Dunyue Lu; Changsheng Qu; Anton Goussev; Zheng Gang Zhang; Chang Lu; Michael Chopp
Journal:  J Neurosurg       Date:  2007-08       Impact factor: 5.115

8.  Neuroprotection by erythropoietin administration after experimental traumatic brain injury.

Authors:  Giovanni Grasso; Alessandra Sfacteria; Francesco Meli; Vincenzo Fodale; Michele Buemi; Domenico G Iacopino
Journal:  Brain Res       Date:  2007-09-14       Impact factor: 3.252

9.  Inosine promotes recovery of skilled motor function in a model of focal brain injury.

Authors:  Justin M Smith; Precious Lunga; David Story; Neil Harris; Janel Le Belle; Michael F James; John D Pickard; James W Fawcett
Journal:  Brain       Date:  2007-02-09       Impact factor: 13.501

Review 10.  Actions of neurotrophic factors and their signaling pathways in neuronal survival and axonal regeneration.

Authors:  Qi Cui
Journal:  Mol Neurobiol       Date:  2006-04       Impact factor: 5.682

View more
  19 in total

Review 1.  A review of neuroprotection pharmacology and therapies in patients with acute traumatic brain injury.

Authors:  Kevin W McConeghy; Jimmi Hatton; Lindsey Hughes; Aaron M Cook
Journal:  CNS Drugs       Date:  2012-07-01       Impact factor: 5.749

2.  Cervical spinal erythropoietin induces phrenic motor facilitation via extracellular signal-regulated protein kinase and Akt signaling.

Authors:  Erica A Dale; Irawan Satriotomo; Gordon S Mitchell
Journal:  J Neurosci       Date:  2012-04-25       Impact factor: 6.167

3.  Dose-dependent neurorestorative effects of delayed treatment of traumatic brain injury with recombinant human erythropoietin in rats.

Authors:  Yuling Meng; Ye Xiong; Asim Mahmood; Yanlu Zhang; Changsheng Qu; Michael Chopp
Journal:  J Neurosurg       Date:  2011-04-15       Impact factor: 5.115

4.  Neuroprotective and neurorestorative effects of thymosin β4 treatment following experimental traumatic brain injury.

Authors:  Ye Xiong; Asim Mahmood; Yuling Meng; Yanlu Zhang; Zheng Gang Zhang; Daniel C Morris; Michael Chopp
Journal:  Ann N Y Acad Sci       Date:  2012-10       Impact factor: 5.691

Review 5.  Neurorestorative treatments for traumatic brain injury.

Authors:  Ye Xiong; Asim Mahmood; Michael Chopp
Journal:  Discov Med       Date:  2010-11       Impact factor: 2.970

6.  Pregnenolone-progesterone-allopregnanolone pathway as a potential therapeutic target in first-episode antipsychotic-naïve patients with schizophrenia.

Authors:  HuaLin Cai; Xiang Zhou; George G Dougherty; Ravinder D Reddy; Gretchen L Haas; Debra M Montrose; Matcheri Keshavan; Jeffrey K Yao
Journal:  Psychoneuroendocrinology       Date:  2018-02-07       Impact factor: 4.905

7.  Erythropoietin promotes neurovascular remodeling and long-term functional recovery in rats following traumatic brain injury.

Authors:  Ruizhuo Ning; Ye Xiong; Asim Mahmood; Yanlu Zhang; Yuling Meng; Changsheng Qu; Michael Chopp
Journal:  Brain Res       Date:  2011-02-03       Impact factor: 3.252

Review 8.  Animal models of traumatic brain injury.

Authors:  Ye Xiong; Asim Mahmood; Michael Chopp
Journal:  Nat Rev Neurosci       Date:  2013-02       Impact factor: 34.870

9.  Role of CB2 Receptor in the Recovery of Mice after Traumatic Brain Injury.

Authors:  Lital Magid; Sami Heymann; Merav Elgali; Liat Avram; Yoram Cohen; Sigal Liraz-Zaltsman; Raphael Mechoulam; Esther Shohami
Journal:  J Neurotrauma       Date:  2019-02-07       Impact factor: 5.269

Review 10.  Pharmacotherapy of traumatic brain injury: state of the science and the road forward: report of the Department of Defense Neurotrauma Pharmacology Workgroup.

Authors:  Ramon Diaz-Arrastia; Patrick M Kochanek; Peter Bergold; Kimbra Kenney; Christine E Marx; Col Jamie B Grimes; L T C Yince Loh; L T C Gina E Adam; Devon Oskvig; Kenneth C Curley; Wanda Salzer
Journal:  J Neurotrauma       Date:  2014-01-15       Impact factor: 5.269

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.